Antigen 85 variation across lineages of Mycobacterium tuberculosis-Implications for vaccine and biomarker success

Journal of Proteomics

Volumn 97, Issue , 2014, Pages 141-150

  Kruh Garcia, Nicole A ^a   Murray, Madeleine ^a   Prucha, John G ^a   Dobos, Karen M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Antigen; MRM; Tuberculosis; Vaccine

Indexed keywords

ANTIGEN; ANTIGEN 85 A; ANTIGEN 85 B; ANTIGEN 85 C; BIOLOGICAL MARKER; MESSENGER RNA; MYCOBACTERIUM VACCINE; UNCLASSIFIED DRUG; BACTERIAL RNA; EPITOPE; GENOMIC DNA; MYCOBACTERIUM ANTIGEN;

ANTIGENIC VARIATION; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DENSITOMETRY; LIMIT OF DETECTION; MASS SPECTROMETRY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYLOGENY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; ANTIGEN EXPRESSION; BACTERIAL GENETICS; GENE EXPRESSION; LIMIT OF QUANTITATION; MOLECULAR PHYLOGENY; PROTEIN CLEAVAGE;

MYCOBACTERIUM TUBERCULOSIS;

ANTIGEN; MRM; TUBERCULOSIS; VACCINE;

ANTIGENS, BACTERIAL; BIOLOGICAL MARKERS; GENETIC VARIATION; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 84892842987     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.07.005     Document Type: Article

References (45)

1. (WHO), W.H.O Global tuberculosis control in WHO Report 2012 2012, WHO, Geneva, Switzerland.
2. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 1994, 62(6):2536-2544.
3. Hubbard R.D., Flory C.M., Collins F.M. Immunization of mice with mycobacterial culture filtrate proteins. Clin Exp Immunol 1992, 87(1):94-98.
4. Pal P.G., Horwitz M.A. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 1992, 60(11):4781-4792.
5. Roberts A.D., Sonnenberg M.G., Ordway D.J., Furney S.K., Brennan P.J., Belisle J.T., et al. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 1995, 85(3):502-508.
6. Nagai S., Wiker H.G., Harboe M., Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 1991, 59(1):372-382.
7. Belisle J.T., Vissa V.D., Sievert T., Takayama K., Brennan P.J., Besra G.S. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 1997, 276(5317):1420-1422.
8. Kuo C.J., Bell H., Hsieh C.L., Ptak C.P., Chang Y.F. Novel mycobacteria antigen 85 complex binding motif on fibronectin. J Biol Chem 2012, 287(3):1892-1902.
9. Abou-Zeid C., Ratliff T.L., Wiker H.G., Harboe M., Bennedsen J., Rook G.A. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect Immun 1988, 56(12):3046-3051.
10. Abou-Zeid C., Harboe M., Rook G.A. Characterization of the secreted antigens of Mycobacterium bovis BCG: comparison of the 46-kilodalton dimeric protein with proteins MPB64 and MPB70. Infect Immun 1987, 55(12):3213-3214.
11. Wiker H.G., Harboe M., Lea T.E. Purification and characterization of two protein antigens from the heterogeneous BCG85 complex in Mycobacterium bovis BCG. Int Arch Allergy Appl Immunol 1986, 81(4):298-306.
12. Wiker H.G., Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 1992, 56(4):648-661.
13. Comas I., Chakravartti J., Small P.M., Galagan J., Niemann S., Kremer K., et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 2010, 42(6):498-503.
14. de Souza G.A., Wiker H.G. A proteomic view of mycobacteria. Proteomics 2011, 11(15):3118-3127.
15. Andersen P., Askgaard D., Ljungqvist L., Bennedsen J., Heron I. Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 1991, 59(6):1905-1910.
16. Ronning D.R., Klabunde T., Besra G.S., Vissa V.D., Belisle J.T., Sacchettini J.C. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines. Nat Struct Biol 2000, 7(2):141-146.
17. Ronning D.R., Vissa V., Besra G.S., Belisle J.T., Sacchettini J.C. Mycobacterium tuberculosis antigen 85A and 85C structures confirm binding orientation and conserved substrate specificity. J Biol Chem 2004, 279(35):36771-36777.
18. Odutola A.A., Owolabi O.A., Owiafe P.K., McShane H., Ota M.O. A new TB vaccine, MVA85A, induces durable antigen-specific responses 14months after vaccination in African infants. Vaccine 2012, 30(38):5591-5594.
19. Aeras Available from: http://www.aeras.org/portfolio/. http://www.aeras.org/portfolio/.
20. Brennan M.J., Stone M.R., Evans T. A rational vaccine pipeline for tuberculosis [State of the art series. New tools. Number 5 in the series]. Int J Tuberc Lung Dis 2012, 16(12):1566-1573.
21. Hoft D.F., Blazevic A., Abate G., Hanekom W.A., Kaplan G., Soler J.H., et al. A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis 2008, 198(10):1491-1501.
22. Pheiffer C., Betts J., Lukey P., van Helden P. Protein expression in Mycobacterium tuberculosis differs with growth stage and strain type. Clin Chem Lab Med 2002, 40(9):869-875.
23. Pheiffer C., Betts J.C., Flynn H.R., Lukey P.T., van Helden P. Protein expression by a Beijing strain differs from that of another clinical isolate and Mycobacterium tuberculosis H37Rv. Microbiology 2005, 151(Pt 4):1139-1150.
24. Mehaffy C., Hess A., Prenni J.E., Mathema B., Kreiswirth B., Dobos K.M. Descriptive proteomic analysis shows protein variability between closely related clinical isolates of Mycobacterium tuberculosis. Proteomics 2010, 10(10):1966-1984.
25. Sonnenberg M.G., Belisle J.T. Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry. Infect Immun 1997, 65(11):4515-4524.
26. Dobos K.M., Swiderek K., Khoo K.H., Brennan P.J., Belisle J.T. Evidence for glycosylation sites on the 45-kilodalton glycoprotein of Mycobacterium tuberculosis. Infect Immun 1995, 63(8):2846-2853.
27. Belisle J.T., Sonnenberg M.G. Isolation of genomic DNA from mycobacteria. Methods Mol Biol 1998, 101:31-44.
28. VanderVen B.C., Harder J.D., Crick D.C., Belisle J.T. Export-mediated assembly of mycobacterial glycoproteins parallels eukaryotic pathways. Science 2005, 309(5736):941-943.
29. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979, 76(9):4350-4354.
30. Kruh N.A., Troudt J., Izzo A., Prenni J., Dobos K.M. Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo. PLoS One 2010, 5(11):e13938.
31. MacLean B., Tomazela D.M., Shulman N., Chambers M., Finney G.L., Frewen B., et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010, 26(7):966-968.
32. Maclean B., Tomazela D.M., Abbatiello S.E., Zhang S., Whiteaker J.R., Paulovich A.G., et al. Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry. Anal Chem 2010, 82(24):10116-10124.
33. Whiteaker J.R., Zhao L., Anderson L., Paulovich A.G. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol Cell Proteomics 2010, 9(1):184-196.
34. Keshishian H., Addona T., Burgess M., Kuhn E., Carr S.A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2007, 6(12):2212-2229.
35. Gagneux S., Small P.M. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 2007, 7(5):328-337.
36. Wiker H.G., Nagai S., Harboe M., Ljungqvist L. A family of cross-reacting proteins secreted by Mycobacterium tuberculosis. Scand J Immunol 1992, 36(2):307-319.
37. Harth G., Lee B.Y., Wang J., Clemens D.L., Horwitz M.A. Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect Immun 1996, 64(8):3038-3047.
38. Malen H., Berven F.S., Fladmark K.E., Wiker H.G. Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 2007, 7(10):1702-1718.
39. Ollinger J., O'Malley T., Ahn J., Odingo J., Parish T. Inhibition of the sole type I signal peptidase of Mycobacterium tuberculosis is bactericidal under replicating and nonreplicating conditions. J Bacteriol 2012, 194(10):2614-2619.
40. Schubert O.T., Mouritsen J., Ludwig C., Rost H.L., Rosenberger G., Arthur P.K., et al. The Mtb proteome library: a resource of assays to quantify the complete proteome of Mycobacterium tuberculosis. Cell Host Microbe 2013, 13(5):602-612.
41. Schluter H., Apweiler R., Holzhutter H.G., Jungblut P.R. Finding one's way in proteomics: a protein species nomenclature. Chem Cent J 2009, 3:11.
42. Jungblut P.R., Holzhutter H.G., Apweiler R., Schluter H. The speciation of the proteome. Chem Cent J 2008, 2:16.
43. Schmidt F., Donahoe S., Hagens K., Mattow J., Schaible U.E., Kaufmann S.H., et al. Complementary analysis of the Mycobacterium tuberculosis proteome by two-dimensional electrophoresis and isotope-coded affinity tag technology. Mol Cell Proteomics 2004, 3(1):24-42.
44. Jungblut P.R., Schaible U.E., Mollenkopf H.J., Zimny-Arndt U., Raupach B., Mattow J., et al. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol Microbiol 1999, 33(6):1103-1117.
45. Berredo-Pinho M., Kalume D.E., Correa P.R., Gomes L.H., Pereira M.P., da Silva R.F., et al. Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur. BMC Microbiol 2011, 11:80.